Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Roche Molecular Diagnostics invests $57.5m in new Californian research facility

Roche Molecular Diagnostics : 04 April, 2008  (Company News)
Roche Molecular Diagnostics (RMD) has opened its new $57.5 million research facility at the company's global headquarters in Pleasanton, California, USA.
The building represents the final phase of consolidation of RMD's West Coast operations into one campus in Pleasanton which now houses close to 500 employees, including 120 members of RMD's research teams previously located in Alameda.

RMD is a world-leading molecular diagnostics company, developing diagnostics designed to provide information allowing healthcare providers to select and monitor patient response to therapy or identify molecular characteristics of a disease. RMD's products also help to ensure the safety of blood and blood products before they are used for medical procedures by using its approved systems to screen donations.

The research building encompasses more than 135,000 square feet on RMD's 33.4 acre campus in the Hacienda Business Park. Designed by a local firm, DES Architects + Engineers under the leadership of Craig Ivancovich, architect and principal, it was then built by another local company, DPR Construction.

The building and its surroundings incorporate numerous features designed to ensure successful green building status, construction and operation, and further demonstrate Roche's ongoing commitment to sustained development and environmental efficiency throughout its global operations.

RMD is working to implement final operational improvements that will enable the new facility to qualify for Leadership in Energy and Environmental Design (LEED) ‘green building’ certification from the US Green Building Council.

'In designing the new building, it was important to us to minimise our environmental footprint while designing a functional space that could support core research functions and state-of-the-art molecular biology research laboratories,' said Daniel O'Day, president and chief executive officer. 'With the development of this new building, we have achieved these goals while creating an optimal space for our employees to focus on their ongoing contributions to improving healthcare for people around the world.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo